The Efficacy and Safety of Dabigatran Etexilate Comparing With Warfarin for the Anticoagulation Treatment of Cerebral Venous Thrombosis :a Pilot Study
Phase of Trial: Phase III
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Venous thrombosis
- Focus Therapeutic Use
- 21 Nov 2017 Status changed from not yet recruiting to recruiting.
- 02 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Aug 2017.
- 18 Jul 2017 New trial record